Long-term remission in a patient with hepatosplenic gammadelta T cell lymphoma treated with bortezomib and high-dose CHOP-like chemotherapy followed by autologous peripheral stem cell transplantation

Ann Hematol. 2008 Dec;87(12):1023-4. doi: 10.1007/s00277-008-0523-7. Epub 2008 Jun 28.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Boronic Acids / therapeutic use*
  • Bortezomib
  • Cyclophosphamide / therapeutic use
  • Doxorubicin / therapeutic use
  • Fatal Outcome
  • Female
  • Humans
  • Lymphoma, T-Cell, Peripheral / drug therapy*
  • Lymphoma, T-Cell, Peripheral / therapy
  • Neoplasm Recurrence, Local*
  • Peripheral Blood Stem Cell Transplantation*
  • Prednisone / therapeutic use
  • Protease Inhibitors / therapeutic use*
  • Pyrazines / therapeutic use*
  • Remission Induction
  • T-Lymphocyte Subsets
  • Transplantation, Autologous
  • Vincristine / therapeutic use

Substances

  • Boronic Acids
  • Protease Inhibitors
  • Pyrazines
  • Vincristine
  • Bortezomib
  • Doxorubicin
  • Cyclophosphamide
  • Prednisone

Supplementary concepts

  • CHOP protocol